Table 4 Acute toxicity of nausea/vomiting in relation to the side effects weight loss, ADL, compliance to RT/CT in primary cervical cancer patients
Acute side effects | Nausea/vomiting n = 56 (%) | CTCAE 2 n = 29 (%) | CTCAE ≥ 3 n = 27 (%) | p-value |
|---|---|---|---|---|
Weight loss | ||||
Yes ≥ 5% | 27 (48.2) | 8 (27.6) | 19 (70.4) | 0.001 |
No < 5% | 29 (51.8) | 21 (72.4) | 8 (29.6) | |
Limiting ADL | ||||
Yes | 17 (30.4) | 3 (10.3) | 14 (51.9) | < 0.001 |
No | 39 (69.6) | 26 (89.7) | 13 (48.1) | |
Compliance RT | ||||
Dose modification/stopped treatment | 8 (14.3) | 1 (3.4) | 7 (25.9) | 0.020 |
No interruption | 48 (85.7) | 28 (96.6) | 20 (74.1) | |
Compliance CT | ||||
Dose modification/stopped treatment | 31 (55.4) | 12 (41.4) | 19 (70.4) | 0.030 |
No interuption | 25 (44.6) | 17 (58.6) | 8 (29.6) | |